1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6E8189DFA7C591B5C852570A5005AC484
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/us-pharmaceutical-budget-and-staffing-excellence-benchmarking-the-resources-required-to-drive-productivity-and-growth
18
19
203.234.214.113
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Products & Services

U.S. Pharmaceutical Budget and Staffing Excellence: Benchmarking the Resources Required to Drive Productivity and Growth

ID: HR-60


Features:

100 Data Graphics

100 Metrics

14 Narratives


Pages: 260


Published: Pre-2014


Delivery Format: Online


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
Best Practices Pharmaceutical Budget and Staffing Benchmark Guide (260 slides) allows pharmaceutical and biotech companies to critically evaluate their budgets and staffing levels in order to enhance organizational efficiencies.


To ensure organizational health and competitiveness, companies must continually identify optimal resource levels for their operations. Sometimes, companies need to grow resources, while at other times, the need is to defend or shrink resources. Best Practices Pharmaceutical Budget and Staffing Benchmark Guide allows pharmaceutical and biotech executives to critically assess the efficiency of key business functions and resource allocations.

Budgeting and staffing data compiled for this study was collected from 36 leading pharmaceutical and biotech companies (see participant list below). Many of the companies provided data for multiple business functions. On average 10 companies participated in each study and make up the benchmark class.

If you have to defend or validate budget and staffing resource decisions, the Best Practices Pharmaceutical Budget and Staffing Benchmark Guide will prove invaluable.


Industries Profiled:
Pharmaceutical; Biotech; Manufacturing; Health Care; Diagnostic; Medical Device


Companies Profiled:
Forest Laboratories; AstraZeneca; Berlex Laboratories; Amgen; Shire Pharmaceuticals; Alexion Pharmaceuticals; Biogen; Abbott; Johnson & Johnson; Sigma-Tau Pharmaceuticals; Biovail Pharaceuticals; KV Pharmaceuticals; Solvay Pharmaceuticals; Boehringer-Ingelheim; MedImmune; Stiefel; Bristol-Myers Squibb; Merck; UCB Pharma; MGI Pharma; Abbott Laboratories; Chiron; Novartis; Cubist Pharmaceuticals; Novo Nordisk; Daiichi Pharmaceuticals; Pfizer; Elli Lilly; Proctor and Gamble; Bayer Specialty Pharmaceuticals

Study Snapshot

The Best Practices Pharmaceutical Budget and Staffing Benchmark Guide provides budget and staffing benchmark data for the following pharmaceutical and biotech business functions:

  • Marketing Operations
  • Marketing Services
  • Sales Support
  • Managed Care
  • State Government Affairs
  • Finance
  • Legal and Compliance

Pharmaceutical and biotech executives and managers can compare their business functions, budgets and FTE (Full Time Equivalent Resources) counts to the industry as a whole, using the following key metrics:
  • FTE per Activity (activities are customized for each business function)
  • FTE Allocation by Broad Business Function
  • Budget Allocation per Business Function
  • Budget Allocation per FTE
  • Budget Allocation Expressed as a Percentage of Sales
  • Sales Per FTE
  • Budget and FTE Allocated per Brand (Marketing Operations only)
  • Segmentation by Sales Revenue for Key Efficiency Metrics

Sample Key Finding

All benchmark data is presented in tables designed to allow viewers easy access. Findings are presented by business function and focus on 4 key efficiency metrics as per the table below: